A

ABVC

ABVC BioPharma, Inc. Common Stock
$1.02
Current Price
AI analysis
Read what the AI thinks of ABVC BioPharma, Inc. Common Stock in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app

Key figures

Dividend per share
—
Yield
—
EPS
-$0.32
P/E
—
Data as of Oct 1
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.

Upcoming events

Quarterly earnings
Nov 2

Posts

No posts about ABVC yet.

About ABVC BioPharma, Inc. Common Stock

ABVC BioPharma is a small US biotechnology company that develops new drugs. It earns almost no revenue today, so it relies on selling shares and on partnerships to pay for its research. Its value rests on whether its experimental treatments succeed in trials and win approval.

Add ABVC to your watchlist

Add ABVC to your watchlist.
Scan with your iPhone camera: this page opens in the app.
  • Its AI analysis
  • Every story about it, live
  • An alert when a wallet trades it
Download on the App Store